Stocks and Investing Stocks and Investing
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022
Wed, March 30, 2022

Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $20 on, Mar 30th, 2022


Published on 2024-10-27 20:13:55 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $24 to $20 on, Mar 30th, 2022.

Jonathan has made no other calls on VINC in the last 4 months.



There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Li Watsek of "Cantor Fitzgerald" Initiated at Buy and Held Target at $25 on, Thursday, December 23rd, 2021